Acquisition by Zein Youssef El of 4721 shares of Aceragen subject to Rule 16b-3

ACGNDelisted Stock   0.75  0.23  23.47%   
About 62% of Aceragen's investor base is looking to short. The analysis of current outlook of investing in Aceragen suggests that many traders are alarmed regarding Aceragen's prospects. Aceragen's investing sentiment overview a quick insight into current market opportunities from investing in Aceragen. Many technical investors use Aceragen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Aceragen Inc director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Aceragen insider trading alert for grant of common stock by Zein Youssef El, the corporate stakeholder, on 5th of August 2023. This event was filed by Aceragen Inc with SEC on 2017-10-05. Statement of changes in beneficial ownership - SEC Form 4

Aceragen Fundamental Analysis

We analyze Aceragen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aceragen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aceragen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Aceragen is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Aceragen Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aceragen stock to make a market-neutral strategy. Peer analysis of Aceragen could also be used in its relative valuation, which is a method of valuing Aceragen by comparing valuation metrics with similar companies.

Peers

Aceragen Related Equities

BPTHBio Path   15.62   
0%
100.0%
ACRVAcrivon Therapeutics,   3.63   
0%
23.0%
RNXTRenovoRx   2.92   
0%
18.0%
SABSSAB Biotherapeutics   1.82   
0%
11.0%
SNGXSoligenix   0.29   
0%
1.0%
ARMPArmata Pharmaceuticals   0.45   
2.0%
0%
ADXNAddex Therapeutics   1.38   
8.0%
0%
AKTXAkari Therapeutics   2.00   
12.0%
0%
ATXIAvenue Therapeutics   2.11   
13.0%
0%
SNTISenti Biosciences   2.49   
15.0%
0%
IBIOIbio   3.62   
23.0%
0%
TPSTTempest Therapeutics   4.49   
28.0%
0%
COCPCocrystal Pharma   5.05   
32.0%
0%
PCSAProcessa Pharmaceuticals   5.26   
33.0%
0%
ACXPAcurx Pharmaceuticals   5.38   
34.0%
0%
QNRXQuoin Pharmaceuticals   6.05   
38.0%
0%
ANEBAnebulo Pharmaceuticals   10.83   
69.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Aceragen Stock

If you are still planning to invest in Aceragen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aceragen's history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Volatility Analysis
Get historical volatility and risk analysis based on latest market data